Exact Mass: 304.0824

Exact Mass Matches: 304.0824

Found 93 metabolites which its exact mass value is equals to given mass value 304.0824, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Melphalan

(2S)-2-amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanoic acid

C13H18Cl2N2O2 (304.0745)


An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - melphalan, the racemic mixture - merphalan, and the dextro isomer - medphalan; toxic to bone marrow, but little vesicant action; potential carcinogen. [PubChem] L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents > D019653 - Myeloablative Agonists D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-acetyl-aspartyl-glutamate (NAAG)

(2S)-2-[(2S)-3-carboxy-2-acetamidopropanamido]pentanedioic acid

C11H16N2O8 (304.0907)


N-Acetylaspartylglutamate (NAAG) is a neuropeptide found in millimolar concentrations in the brain that is localized to subpopulations of glutamatergic, cholinergic, GABAergic, and noradrenergic neuronal systems. NAAG is released upon depolarization by a Ca(2+)-dependent process and is an agonist at mGluR3 receptors and an antagonist at NMDA receptors. NAAG is catabolized to N-acetylaspartate and glutamate primarily by glutamate carboxypeptidase II, which is expressed on the extracellular surface of astrocytes. The levels of NAAG and the activity of carboxypeptidase II are altered in a regionally specific fashion in several neuropsychiatric disorders (PMID:9361299). N-Acetylaspartylglutamic acid (NAAG) is a purported precursor of N-acetylaspartic acid (NAA) and is present at about one-tenth of the concentration of NAA in the brain. NAAG has been reported to activate N-methyl-D-aspartic acid (NMDA) receptors in neurons. Previous immunohistochemical studies in the vertebrate central nervous system (CNS) have suggested that NAAG is exclusively localized to neurons. Recent evidence, however, indicates that NAAG might also be localized to nonneuronal cells within the CNS. Only traces of NAA and NAAG are detectable in other tissues. Some compounds can change levels of NAA and NAAG in the brain. For example, methylphenidate increases the levels of NAA and NAAG in the cerebral cortex; amphetamine also increases NAA concentration in a mature brain by 26\\\%, raising the possibility that other neurochemical systems might be involved in the clinical effects of stimulants (PMID:10603234). N-Acetylaspartylglutamate (NAAG) is a neuropeptide found in millimolar concentrations in brain that is localized to subpopulations of glutamatergic, cholinergic, GABAergic, and noradrenergic neuronal systems. NAAG is released upon depolarization by a Ca(2+)-dependent process and is an agonist at mGluR3 receptors and an antagonist at NMDA receptors. NAAG is catabolized to N-acetylaspartate and glutamate primarily by glutamate carboxypeptidase II, which is expressed on the extracellular surface of astrocytes. The levels of NAAG and the activity of carboxypeptidase II are altered in a regionally specific fashion in several neuropsychiatric disorders. (PMID 9361299) D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D009676 - Noxae > D009498 - Neurotoxins D018926 - Anti-Allergic Agents D020011 - Protective Agents Spaglumic Acid (N-Acetylaspartylglutamic acid) is a neuropeptide found in millimolar concentrations in brain.

   

Propaphos

(4-Methylsulphanylphenyl) dipropyl phosphoric acid

C13H21O4PS (304.0898)


   

Tetrangulol

Tetrangulol

C19H12O4 (304.0736)


A member of the class of tetraphenes that is tetraphene-7,12-dione substituted by hydroxy groups at positions 1 and 8 and a methyl group at position 3.

   

Medphalan

2-amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanoic acid

C13H18Cl2N2O2 (304.0745)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D019653 - Myeloablative Agonists D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents

   

spaglumic acid

N-acetyl-L-aspartyl-L-glutamate

C11H16N2O8 (304.0907)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C29714 - Mast Cell Stabilizer D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D009676 - Noxae > D009498 - Neurotoxins D018926 - Anti-Allergic Agents D020011 - Protective Agents Spaglumic Acid (N-Acetylaspartylglutamic acid) is a neuropeptide found in millimolar concentrations in brain.

   

Medphalan

Medphalan

C13H18Cl2N2O2 (304.0745)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D019653 - Myeloablative Agonists D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents

   

Musanolone E

2,3-Dihydroxy-9-(4-hydroxyphenyl)-1H-phenalen-1-one

C19H12O4 (304.0736)


Musanolone E is found in fruits. Musanolone E is a constituent of Musa acuminata (dwarf banana). Constituent of Musa acuminata (dwarf banana). Musanolone E is found in fruits.

   

4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one

4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one

C19H12O4 (304.0736)


4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one is found in fruits. 4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one is isolated from Musa acuminata (dwarf banana). Isolated from Musa acuminata (dwarf banana). 4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one is found in fruits.

   

2-(4-Methoxyphenyl)naphthalic anhydride

6-(4-methoxyphenyl)-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5,7,9(13),10-pentaene-2,4-dione

C19H12O4 (304.0736)


2-(4-Methoxyphenyl)naphthalic anhydride is found in fruits. 2-(4-Methoxyphenyl)naphthalic anhydride is isolated from the unripe banana fruit (Musa acuminata) infected with Colletotrichum musae. Isolated from the unripe banana fruit (Musa acuminata) infected with Colletotrichum musae. 2-(4-Methoxyphenyl)naphthalic anhydride is found in fruits.

   

Demonomethylchlorpromazine

[3-(2-chloro-10H-phenothiazin-10-yl)propyl](methyl)amine

C16H17ClN2S (304.0801)


Demonomethylchlorpromazine is a metabolite of chlorpromazine. Chlorpromazine (as chlorpromazine hydrochloride, abbreviated CPZ; marketed in the United States as Thorazine and elsewhere as Largactil) is a typical antipsychotic. First synthesized on December 11, 1950, chlorpromazine was the first drug developed with specific antipsychotic action, and would serve as the prototype for the phenothiazine class of drugs, which later grew to comprise several other agents. (Wikipedia)

   

Clobuzarit

2-({4-chloro-[1,1-biphenyl]-4-yl}methoxy)-2-methylpropanoic acid

C17H17ClO3 (304.0866)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

Flobufen

4-{2,4-difluoro-[1,1-biphenyl]-4-yl}-2-methyl-4-oxobutanoic acid

C17H14F2O3 (304.0911)


   

Pterocarpanquinone

3,12-dioxapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-1(13),4,6,8,15,17,19-heptaene-14,21-dione

C19H12O4 (304.0736)


   

Methyl clofenapate

Methyl 2-({4-chloro-[1,1-biphenyl]-4-yl}oxy)-2-methylpropanoic acid

C17H17ClO3 (304.0866)


   

N-Acetyl-1-aspartylglutamic acid

2-({3-carboxy-1-hydroxy-2-[(1-hydroxyethylidene)amino]propylidene}amino)pentanedioate

C11H16N2O8 (304.0907)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D009676 - Noxae > D009498 - Neurotoxins D018926 - Anti-Allergic Agents D020011 - Protective Agents Spaglumic Acid (N-Acetylaspartylglutamic acid) is a neuropeptide found in millimolar concentrations in brain.

   

Haemodordione

Haemodordione

C19H12O4 (304.0736)


   

Arofylline

Arofylline

C14H13ClN4O2 (304.0727)


C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

   
   

DTXSID60789203

DTXSID60789203

C19H12O4 (304.0736)


   

2-Hydroxy-8-(3,4-dihydroxyphenyl)-1H-phenalen-1-one

2-Hydroxy-8-(3,4-dihydroxyphenyl)-1H-phenalen-1-one

C19H12O4 (304.0736)


   

Xanthocillin Y1

Xanthocillin Y1

C18H12N2O3 (304.0848)


   

Dihydroxyanigorufone

Dihydroxyanigorufone

C19H12O4 (304.0736)


   

Linderaggrine A

Linderaggrine A

C18H12N2O3 (304.0848)


   

(R)-3-(allylthio)-2-((R)-3-(allylthio)-2-aminopropanamido)propanoic acid

(R)-3-(allylthio)-2-((R)-3-(allylthio)-2-aminopropanamido)propanoic acid

C12H20N2O3S2 (304.0915)


   

2,5,6-trihydroxy-7-phenylphenalen-1-one|2,5,6-trihydroxy-9-phenylphenalen-1-one|lachnanthoside aglycone

2,5,6-trihydroxy-7-phenylphenalen-1-one|2,5,6-trihydroxy-9-phenylphenalen-1-one|lachnanthoside aglycone

C19H12O4 (304.0736)


   

4,7-Diphenyl-1,3-benzodioxole-5,6-dione

4,7-Diphenyl-1,3-benzodioxole-5,6-dione

C19H12O4 (304.0736)


   

5-Methoxy-7-phenyl-1H,6H-naphtho[1,8-cd]pyran-1,6-dione

5-Methoxy-7-phenyl-1H,6H-naphtho[1,8-cd]pyran-1,6-dione

C19H12O4 (304.0736)


   

N-Acetyl-Asp-Glu

N-Acetyl-Asp-Glu

C11H16N2O8 (304.0907)


   

N-Acetylaspartylglutamic acid

N-Acetylaspartylglutamic acid

C11H16N2O8 (304.0907)


   

2-(4-Methoxyphenyl)naphthalic anhydride

6-(4-methoxyphenyl)-3-oxatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C19H12O4 (304.0736)


   

4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one

4-(3,4-Dihydroxyphenyl)-2-hydroxy-1H-phenalen-1-one

C19H12O4 (304.0736)


   

Musanolone E

2,3-Dihydroxy-9-(4-hydroxyphenyl)-1H-phenalen-1-one

C19H12O4 (304.0736)


   

4-methyl-n-(2-oxo-2,5,6,7-tetrahydro-1h-cyclopenta[b]pyridin-4-yl)benzenesulfonamide

4-methyl-n-(2-oxo-2,5,6,7-tetrahydro-1h-cyclopenta[b]pyridin-4-yl)benzenesulfonamide

C15H16N2O3S (304.0882)


   

4-amino-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl 4-methylbenzenesulfonate

4-amino-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl 4-methylbenzenesulfonate

C15H16N2O3S (304.0882)


   

L-Phenylalanine,3-[bis(2-chloroethyl)amino]-

L-Phenylalanine,3-[bis(2-chloroethyl)amino]-

C13H18Cl2N2O2 (304.0745)


   

N-(8-AMINO-6-FLUORO-5-METHYL-1-OXO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)-2,2,2-TRIFLUOROACETAMIDE

N-(8-AMINO-6-FLUORO-5-METHYL-1-OXO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)-2,2,2-TRIFLUOROACETAMIDE

C13H12F4N2O2 (304.0835)


   

Bendazac sodium salt

Bendazac sodium salt

C16H13N2NaO3 (304.0824)


   

N-[2-(2-aminoethylamino)ethyl]propane-1,3-diamine,tetrahydrochloride

N-[2-(2-aminoethylamino)ethyl]propane-1,3-diamine,tetrahydrochloride

C7H24Cl4N4 (304.0755)


   

5-Phenyl-2-(trifluoromethyl)-1H-indole-7-carboxamide

5-Phenyl-2-(trifluoromethyl)-1H-indole-7-carboxamide

C16H11F3N2O (304.0823)


   

4,4,5,5-TETRAMETHYL-2-(4-((TRIFLUOROMETHYL)THIO)PHENYL)-1,3,2-DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(4-((TRIFLUOROMETHYL)THIO)PHENYL)-1,3,2-DIOXABOROLANE

C13H16BF3O2S (304.0916)


   

tert-butyl N-[2-amino-2-(2,4-dichlorophenyl)ethyl]carbamate

tert-butyl N-[2-amino-2-(2,4-dichlorophenyl)ethyl]carbamate

C13H18Cl2N2O2 (304.0745)


   

4-Nitrophenylphosphorylcholine

4-Nitrophenylphosphorylcholine

C11H17N2O6P (304.0824)


   

2-(1,3-DIOXOLAN-2-YL)BENZYL PHENYL SULFONE

2-(1,3-DIOXOLAN-2-YL)BENZYL PHENYL SULFONE

C16H16O4S (304.0769)


   

Carbonothioic acid S-(4,6-dimethyl-2-pyrimidinyl) O-[(4-methoxyphenyl)methyl] ester

Carbonothioic acid S-(4,6-dimethyl-2-pyrimidinyl) O-[(4-methoxyphenyl)methyl] ester

C15H16N2O3S (304.0882)


   

4-(p-Tolylthio)benzophenone

4-(p-Tolylthio)benzophenone

C20H16OS (304.0922)


   

Acide spaglumique

Acide spaglumique

C11H16N2O8 (304.0907)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Dicyclohexyliodoborane

Dicyclohexyliodoborane

C12H22BI (304.0859)


   

3-(t-Butyldimethylsilyloxy)-4-chloro-2-fluorophenylboronic acid

3-(t-Butyldimethylsilyloxy)-4-chloro-2-fluorophenylboronic acid

C12H19BClFO3Si (304.0869)


   

7-HYDROXY-3-(1-PHENYL-1H-PYRAZOL-4-YL)-CHROMEN-4-ONE

7-HYDROXY-3-(1-PHENYL-1H-PYRAZOL-4-YL)-CHROMEN-4-ONE

C18H12N2O3 (304.0848)


   

N-(5-amino-2-chlorophenyl)-4,4-dimethyl-3-oxovaleramide

N-(5-amino-2-chlorophenyl)-4,4-dimethyl-3-oxovaleramide

C13H18Cl2N2O2 (304.0745)


   

N,N-DIETHYL-2-OXO-1,2-DIHYDROBENZO[CD]INDOLE-6-SULFONAMIDE

N,N-DIETHYL-2-OXO-1,2-DIHYDROBENZO[CD]INDOLE-6-SULFONAMIDE

C15H16N2O3S (304.0882)


   

1-(3-PYRIDIN-3-YL-[1,2,4]OXADIAZOL-5-YL)-ETHYLAMINE

1-(3-PYRIDIN-3-YL-[1,2,4]OXADIAZOL-5-YL)-ETHYLAMINE

C11H11F3N4O3 (304.0783)


   

[3-(Dibenzo[b,d]thiophen-4-yl)phenyl]boronic acid

[3-(Dibenzo[b,d]thiophen-4-yl)phenyl]boronic acid

C18H13BO2S (304.0729)


   

2-(4-CHLOROPHENYL)-1,3-BIS(1H-1,2,4-TRIAZOL-1-YL)-2-PROPANOL

2-(4-CHLOROPHENYL)-1,3-BIS(1H-1,2,4-TRIAZOL-1-YL)-2-PROPANOL

C13H13ClN6O (304.0839)


   

3-(4-tolysulfonyl)-4-aminoacetanilide

3-(4-tolysulfonyl)-4-aminoacetanilide

C15H16N2O3S (304.0882)


   

4-C-azido-2-deoxy-2,2-difluorocytidine

4-C-azido-2-deoxy-2,2-difluorocytidine

C9H10F2N6O4 (304.0732)


   

(6-phenyldibenzo[b,d]thiophen-4-yl)boronic acid

(6-phenyldibenzo[b,d]thiophen-4-yl)boronic acid

C18H13BO2S (304.0729)


   

B-[4-(4-dibenzothienyl)phenyl]-boronic acid

B-[4-(4-dibenzothienyl)phenyl]-boronic acid

C18H13BO2S (304.0729)


   

2-(4-dibenzothienyl)phenylboronic acid

2-(4-dibenzothienyl)phenylboronic acid

C18H13BO2S (304.0729)


   

2,3-dihydro-1-benzofuran-2-ylmethyl 4-methylbenzenesulfonate

2,3-dihydro-1-benzofuran-2-ylmethyl 4-methylbenzenesulfonate

C16H16O4S (304.0769)


   

DIETHYL 3-TRIFLUOROMETHYLPHENYL MALONATE

DIETHYL 3-TRIFLUOROMETHYLPHENYL MALONATE

C14H15F3O4 (304.0922)


   

(1-Hydroxynonane-1,1-Diyl)bis(Phosphonic Acid)

(1-Hydroxynonane-1,1-Diyl)bis(Phosphonic Acid)

C9H22O7P2 (304.0841)


   

Methyl clofenapate

Methyl clofenapate

C17H17ClO3 (304.0866)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites

   

Flobufen

Flobufen

C17H14F2O3 (304.0911)


D018501 - Antirheumatic Agents

   

Norchlorpromazine

Norchlorpromazine

C16H17ClN2S (304.0801)


   

3,12-Dioxapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),4,6,8,15,17,19-heptaene-14,21-dione

3,12-Dioxapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),4,6,8,15,17,19-heptaene-14,21-dione

C19H12O4 (304.0736)


   

Chlorphenethazine

Chlorphenethazine

C16H17ClN2S (304.0801)


   

N-(1-naphthalenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine

N-(1-naphthalenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine

C17H12N4S (304.0783)


   

Ethyl 5-amino-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxylate

Ethyl 5-amino-3-methyl-4-(phenylcarbamoyl)thiophene-2-carboxylate

C15H16N2O3S (304.0882)


   

N-(6-methyl-2-pyridinyl)-2-(phenylmethyl)sulfonylacetamide

N-(6-methyl-2-pyridinyl)-2-(phenylmethyl)sulfonylacetamide

C15H16N2O3S (304.0882)


   

N-Sulfanilyl-3,4-xylamide

N-Sulfanilyl-3,4-xylamide

C15H16N2O3S (304.0882)


   

N5-[(S)-Citryl]-D-ornithine

N5-[(S)-Citryl]-D-ornithine

C11H16N2O8-2 (304.0907)


   

(citryl)-N-(3-aminopropyl)-N-hydroxyacetamide

(citryl)-N-(3-aminopropyl)-N-hydroxyacetamide

C11H16N2O8-2 (304.0907)


   

N-Acetyl-1-aspartylglutamic acid

N-Acetyl-1-aspartylglutamic acid

C11H16N2O8 (304.0907)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D009676 - Noxae > D009498 - Neurotoxins D018926 - Anti-Allergic Agents D020011 - Protective Agents

   

4-[(3-cyano-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl)thio]-3-oxobutanoic acid ethyl ester

4-[(3-cyano-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl)thio]-3-oxobutanoic acid ethyl ester

C15H16N2O3S (304.0882)


   

(2R)-2-[[(3S)-3-acetamido-3-carboxy-1-oxopropyl]amino]pentanedioic acid

(2R)-2-[[(3S)-3-acetamido-3-carboxy-1-oxopropyl]amino]pentanedioic acid

C11H16N2O8 (304.0907)


   

1-(2-Chlorophenyl)-3-(3-phenylpropyl)thiourea

1-(2-Chlorophenyl)-3-(3-phenylpropyl)thiourea

C16H17ClN2S (304.0801)


   

N(5)-[(S)-citryl]-D-ornithine

N(5)-[(S)-citryl]-D-ornithine

C11H16N2O8-2 (304.0907)


   

[4-(2-Phenylcyclobutyl)phenyl] hydrogen sulate

[4-(2-Phenylcyclobutyl)phenyl] hydrogen sulate

C16H16O4S (304.0769)


   

melphalan

melphalan

C13H18Cl2N2O2 (304.0745)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues A phenylalanine derivative comprising L-phenylalanine having [bis(2-chloroethyl)amino group at the 4-position on the phenyl ring. D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000970 - Antineoplastic Agents > D019653 - Myeloablative Agonists D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

Sarcolysin

Sarcolysin

C13H18Cl2N2O2 (304.0745)


D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D019653 - Myeloablative Agonists D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D009676 - Noxae > D000477 - Alkylating Agents

   

N-Acetyl-alpha-aspartylglutamic acid

N-Acetyl-alpha-aspartylglutamic acid

C11H16N2O8 (304.0907)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D009676 - Noxae > D009498 - Neurotoxins D018926 - Anti-Allergic Agents D020011 - Protective Agents

   

Clozic

Clobuzarit

C17H17ClO3 (304.0866)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

Ac-Asp-Glu

Ac-Asp-Glu

C11H16N2O8 (304.0907)


A dipeptide composed of N-acetyl-L-aspartic acid and L-glutamic acid joined by a peptide linkage.

   

9-(3,4-dihydroxyphenyl)-2-hydroxyphenalen-1-one

9-(3,4-dihydroxyphenyl)-2-hydroxyphenalen-1-one

C19H12O4 (304.0736)


   

2,5,6-trihydroxy-9-phenylphenalen-1-one

2,5,6-trihydroxy-9-phenylphenalen-1-one

C19H12O4 (304.0736)


   

4-methoxy-5-phenyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),4,9,11-pentaene-3,6-dione

4-methoxy-5-phenyl-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),2(7),4,9,11-pentaene-3,6-dione

C19H12O4 (304.0736)


   

2-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-4-one

2-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-4-one

C12H16O9 (304.0794)


   

7-methoxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,6,9(13),10-pentaene-2,8-dione

7-methoxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,6,9(13),10-pentaene-2,8-dione

C19H12O4 (304.0736)


   

2-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-4-one

2-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pyran-4-one

C12H16O9 (304.0794)